Obesity in the elderly: who should we be treating, and why, and how?Kennedy, R Lee; Chokkalingham, Kamal; Srinivasan, RamalingamCurrent Opinion in Clinical Nutrition and Metabolic Care: January 2004 - Volume 7 - Issue 1 - p 3-9 Ageing: biology and nutrition Buy Abstract Author InformationAuthors Purpose of review To investigate emerging data on the relationship between obesity, increased morbidity and mortality, and decreased function in the elderly. To examine what is known about the effectiveness of interventions, and how treatment might be improved. Recent findings Obesity is a common problem in the elderly, although its prevalence decreases in extreme old age. Decreased physical activity and decreased energy expenditure with ageing predispose to fat accumulation and fat redistribution. Reduction in muscle mass (sarcopenic obesity) is an important determinant of physical function and metabolic rate. Chronic inflammation and endocrine changes contribute to the changes in metabolism and body composition that accompany ageing, and are potential therapeutic targets. Body weight and body mass index are imperfect indicators of risk from obesity. The focus of treatment should be on reduction of intra-abdominal fat and preservation of muscle mass and strength. A number of recent studies have confirmed the effectiveness of exercise interventions in the elderly. Progressive resistance training, rather than endurance exercise, may be more effective in many cases. Reduced function and decreased quality of life accompany development of the complications of obesity such as diabetes and vascular disorders. There is considerable scope to impede the development of these complications in the elderly with lifestyle interventions. Summary Sarcopenic obesity, with accumulation of intra-abdominal fat, is a major determinant of health status in the elderly. As in the younger population, prevention and treatment programmes have the potential to decrease the impact of diabetes, vascular disease, and other complications of obesity. Department of Diabetes, Endocrinology and Nutrition, Queen's Medical Centre, Nottingham, UK Correspondence to R.L. Kennedy, MD PhD, Department of Diabetes, Endocrinology and Nutrition, C Floor, South Block, Queen's Medical Centre University Hospital, Derby Road, Nottingham NG7 2UH, UK Tel: +44 115 924 9924 (x43114); fax: +44 115 849 3304; e-mail: firstname.lastname@example.org © 2004 Lippincott Williams & Wilkins, Inc.